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The vast majority of animal viruses enhance membrane permeability at two moments of infection. Herein, we describe that the entry of
Sindbis virus (SV) in BHK cells promotes the co-entry of the macromolecule alpha-sarcin into the cytoplasm, thereby blocking translation.
At a later stage, this protein toxin cannot enter the cell, while low molecular weight compounds, such as hygromycin B, readily pass through
the plasma membrane of Sindbis virus-infected BHK cells. To unveil the participation of the different Sindbis virus structural proteins in late
permeabilization, transfection experiments with each late gene by separate have been carried out. Our findings indicate that 6K is the main
determinant that enhances membrane permeabilization. The co-expression of both viral glycoproteins employing a Sindbis virus variant that
lacks the entire 6K gene partly modifies membrane permeability. Brefeldin A, a macrolide antibiotic that interferes with the proper
functioning of the vesicular system, hampers the induction of membrane leakiness without significantly affecting viral protein synthesis. On
the other hand, the flavone compound Ro-090179 also diminishes the entry of hygromycin B, while bafilomycin A1 or nocodazole have no
effect. These data reveal the requirement of the vesicular system for late viral membrane permeabilization.
D 2004 Elsevier Inc. All rights reserved.
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A large variety of animal viruses enhance membrane
permeability during infection (Carrasco, 1994, 1995; Car-
rasco et al., 1993; Kelly et al., 2003). To date, two different
mechanisms of viral membrane permeabilization have been
established: one occurring early in infection, in which the
entry of virus particles into the cells leads to the co-entry of
molecules present in the culture medium; and a later
mechanism whereby the plasma membrane becomes leaky
when the viral structural components are being synthesized
(Carrasco, 1994, 1995). Two different types of viral protein
have been found to induce late membrane leakiness:
glycoproteins with the ability to alter cell membrane
permeability upon their expression (Arroyo et al., 1995;
Ciccaglione et al., 2003; Comardelle et al., 1997; Cherno-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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2003) and small, very hydrophobic membrane proteins
collectively known as viroporins (Carrasco, 1995; Gonzalez
and Carrasco, 2003). In addition, the HIV-1 protease is also
able to induce cell lysis (Blanco et al., 2003).
Sindbis virus (SV) belongs to the alphavirus genus and
has a plus strand RNA as genome (Schlesinger et al., 2001;
Strauss and Strauss, 1994). SV infection starts by virion
attachment to a cell receptor, followed by endocytosis, and
low pH-mediated fusion of the viral envelope with the
endosome membrane. Viral replication ensues in the
cytoplasm. The newly made genomic RNAs are then
encapsidated and the viral progeny egress by budding from
the cell membrane. Alphavirus infection modifies a number
of cellular processes such as membrane functioning,
whereby intracellular monovalent cation levels are modified
as SV infection progresses (Ulug et al., 1984). The
alphavirus Semliki Forest virus (SFV) also induces changes
in cell permeability (Munoz et al., 1985). The alphavirus 6K05) 307–315
Fig. 1. Early and late membrane permeabilization induced by SV infection
of BHK cells. Mock-infected or SV infected BHK cells at 100 pfu/cell were
labeled with [35S]Met-Cys in the absence () or presence of 1 mM HB or
100 Ag/ml alpha-sarcin (a-Sar). (A) Labeling of mock infected cells. (B)
Cells labeled at 30 min post-infection. (C) Cells labeled at 6 h post-infection
(h.p.i). Next, samples were processed for SDS-PAGE, fluorography and
autoradiography as indicated in Materials and methods. Labeled proteins
were subjected to densitometric analysis to estimate the percentage of
protein translation inhibition associated with the entry of HB or alpha-
sarcin. The numbers below each line represent the percentages obtained by
dividing the densitometred values for treated cells by equivalent values for
untreated cells. The densitometred proteins were Sindbis C protein and a
cellular protein marked with the symbol (*) in the gel.
V. Madan et al. / Virology 332 (2005) 307–315308protein has been shown to be involved in membrane
modification both in bacterial and mammalian cells (Melton
et al., 2002; Sanz et al., 1994, 2003a). There is also direct
evidence that 6K proteins from Ross River virus (RRV) and
Barmah Forest virus (BFV) have the ability to form pores in
artificial membranes (Melton et al., 2002). Further, E1
seems to provoke membrane permeabilization in response to
low pH-exposure in bacteria (Nyfeler et al., 2001). During
early stages of infection, E1 glycoprotein forms ion-
permeable pores in endocytic membranes activated by low
pH (Wengler et al., 2003). The physical mechanism that
leads to membrane permeabilization is still not fully
understood. The fine details of this mechanism may differ
according to the inducing molecule analyzed, although all
these alphavirus proteins that alter permeability are capable
of forming pores in membranes.
Bafilomycin A1, a selective inhibitor of vacuolar proton-
ATPase (Drose and Altendorf, 1997), blocks the co-entry of
the toxin alpha-sarcin induced by several animal viruses,
including SFV. The co-entry of macromolecules along with
the virions requires the formation of a proton gradient
(Guinea and Carrasco, 1995; Irurzun and Carrasco, 2001;
Perez and Carrasco, 1994). In accordance with these results,
a model to explain these changes in early membrane
permeability has been developed (Carrasco, 1994) although
there are still a number of questions regarding the
mechanisms of late membrane leakiness that need further
clarification. For instance, it is not yet known if viroporins
exert their permeabilization activity from an internal
subcellular compartment or if physical pores are directly
generated by viroporins at the plasma membrane. The
immunolocalization of Coxsackie virus 2B protein reveals it
mainly occurs at the Golgi apparatus (De Jong et al., 2003;
van Kuppeveld et al., 1997). Some authors have postulated
that it may modify the plasma membrane indirectly from an
internal cellular compartment (De Jong et al., 2003, 2004).
We now describe that an inhibitor of the vesicular system
such as Brefeldin A (BFA) abolishes the enhancement of
permeability during SV infection or its enhancement
through the expression of the viroporin 6K. The results
presented also lend support to the idea that 6K is a major
determinant in this phenomenon, although viral glycopro-
teins also participate in membrane leakiness.Results
Early and late cell permeabilization by SV
Most animal viruses permeabilize cells during the
process of virus entry. As shown in Fig. 1, this is also the
case for SV. The virus particles specifically and efficiently
promote the entry of alpha-sarcin (MW 16,800) at early time
points during infection, while the aminoglycoside antibiotic
hygromycin B (HB) (MW 527) penetrates the cells less
efficiently (Fig. 1B). In the later stages of SV infection,when viral structural proteins are being synthesized, HB
readily enters cells, whereas the macromolecule alpha-sarcin
is excluded (Fig. 1C). These findings are consistent with the
idea that the enhanced membrane permeability observed late
in the infection process is provoked by the presence of
membrane pores that excluded the entry of macromolecules.
Viral products promoting late membrane leakiness
The precise contribution of the different SV structural
proteins to enhancing late permeabilization is still unknown.
To address this question, all late SV proteins were
individually synthesized in BHK cells. Replication of the
SV genome followed by the synthesis of protein C (see
scheme rep C, Fig. 2A) was insufficient to perturb the
plasma membrane (Fig. 2B). Besides, the constructs
encoding C+PE2 (rep C + E3E2) and C + 6K (rep C +
D(E3/E2)6K) were used and a new replicon encoding C +
E1 (rep C + D(E3/E2)E1) was engineered. In the case of E1
and 6K constructs, they encode, in addition, the sequence
D(E3/E2), which contained the 45 amino-terminal amino
acids of E3 fused to 31 carboxy-terminal residues of E2.
Our rationale for including these extra sequences was based
Fig. 2. Membrane permeabilization induced by the different SV structural proteins. (A) Schematic representation of the different SV-derived RNAs. (B) BHK
cells were electroporated with in vitro synthesized RNA from the different constructs shown in the figure. At 16 h post-electroporation (h.p.e), cells were
labeled with [35S]Met-Cys in the absence () or presence (+) of 1 mM HB as indicated in the figure. Next, samples were processed for SDS-PAGE,
fluorography, and autoradiography. (C) BHK cells were electroporated with in vitro synthesized RNA corresponding to the replicons C + D(E3/E2)6K or C +
6K. At 16 h.p.e, cells were labeled and processed as indicated above. The numbers below each line represent the percentages obtained by dividing the
densitometred values for cells treated with HB by equivalent values for untreated cells. Protein C was used to obtain the densitometred values.
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of the nascent protein to the endoplasmic reticulum (ER)
occurs at the N-terminal end of E3. Thus, in previous
experiments, a construct that only coded for C and E1
produced an E1 product that was not translocated to the ER
and was readily degraded (Sanz et al., 2003b). The presence
of D(E3/E2) not only promotes the correct translocation and
insertion of E1 at the ER membrane, but also its proteolytic
processing from 6K or E1 by ER signalases. The separate
synthesis of each viral glycoprotein altered permeabilization
to a limited extent (Fig. 2B). Notably, the synthesis of 6K
led to significant entry of the aminoglycoside antibiotic HB
(Fig. 2B). This antibiotic entry promoted by 6K led to a
reduced percentage of translation that ranged from 1% to
6% as determined in four independent experiments. These
data indicate that 6K is the main determinant of late
membrane leakiness.
The 6K protein synthesized above contained a genuine
sequence since the cleavage junction between E2 and 6K
persisted. However, the product D(E3/E2) could in itself
also exert some permeabilization activity. To address this,another 6K protein was engineered that lacks D(E3/E2) and
bearing only four codons between C and 6K (see scheme
rep C + 6K, Fig. 2A). The four extra amino acids (SAHM)
provide a cleavage site between C and 6K. This 6K
permeabilized BHK cells to a similar extent as compared
to D(E3/E2)6K (Fig. 2C). This result suggests that 6K has
an inherent ability to permeabilize cells even when
synthesized out of the context of the viral polyprotein.
Once synthesized, alphavirus glycoproteins oligomerize
to travel to the plasma membrane, giving rise to the typical
spikes that participate in virus budding (Zhang et al., 2002).
Thus, we then went on to test the effects on permeabilization
when both glycoproteins, E1 and E2, were synthesized
together. To this end, we generated a 6K-deficient SV
variant (D6K SV) that lacked the entire 6K gene. This SV
variant retains the ability to process both glycoproteins and
is able to form virus particles, albeit less efficiently than wt
SV. BHK cells infected with the 6K-deleted variant
exhibited a delayed cytopathic effect, as compared with
cells infected with wt SV (Fig. 3A). Despite this deletion,
the 6K-deficient SV retained some of its ability to
Fig. 3. Comparison of BHK cell infection by wt or D6K SV. (A) Cytopathic effect observed in the infected cells. Cells infected with wt or D6K SV were
examined using a phase-contrast microscope at 15 or 22 h.p.i. (B) Membrane permeabilization induced by the viruses. BHK cells were infected with 100 pfu/
cell of wt or D6K SV. At 3, 6 and 12 h.p.i, cells were labeled in the absence () or presence (+) of 1 mM HB and processed for SDS-PAGE, fluorography and
autoradiography. The numbers below each line represent the percentages obtained by dividing the densitometred values for HB-treated cells by equivalent
values for untreated cells. Protein C was used to obtain the densitometred values.
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lization activity is due to the accumulation of glycoproteins
at the plasma membrane since virus budding is impaired in
this SV variant.
BFA abolishes membrane permeabilization
An important issue to be considered is whether the viral
products exert their permeabilization activity directly by
forming pores at the plasma membrane, or if they act
indirectly. In this last case, it has been speculated that
viroporins, such as Coxsackie virus 2B protein, do not need
to reach the plasma membrane and can alter membrane
permeability from an intracellular compartment (De Jong et
al., 2003, 2004). If this is so, after synthesis, the viroporin
may produce a signal that opens a cell pore already located
at the plasma membrane. To get further insight into the
action of 6K, we made use of the inhibitor BFA, a macrolide
fungal antibiotic known to rapidly disorganize the Golgi
complex and redistributes cis-, medial, and trans-Golgi
markers into the ER (Klausner et al., 1992; Lippincott-
Schwartz et al., 1989, 1990, 1991; Miller et al., 1992;
Yewdell and Bennink, 1989). The action of BFA has been
explained by an inhibition of the anterograde vesicular
traffic from ER to Golgi, between Golgi stacks, and from
post-Golgi to plasma membrane, without effect on retro-
grade transport (Lippincott-Schwartz et al., 1989; Miller et
al., 1992). The molecular mechanism of action of BFA
action is based on the inhibition of a subset of Sec7-type
GTP-exchange factors (GEFs) that catalyze the activation of
a small GTP-binding protein, ADP-ribosylation factor 1, or
ARF1 (Jackson and Casanova, 2000). This inhibition leads
to the release from Golgi membranes of the COPI coat and
AP-1/clathrin coat protein complexes implicated in the
formation of transport vesicles (Scales et al., 2000). BFAinhibits togavirus growth by blockade of proper glycopro-
tein processing and virus particle maturation. Contrary to
effects in some picornaviruses, BFA does not inhibit the
replication of alphavirus genomes (Irurzun et al., 1992;
Perez et al., 1994). Thus, the synthesis of late SV proteins is
not impaired by the presence of BFA. Remarkably, the
addition of BFA 2 h after infection impaired the permeabi-
lization induced by SV infection (Fig. 4A). The levels of
synthesis of late virus proteins were similar in the absence or
presence of BFA, indicating that the synthesis of viral
proteins is insufficient to enhance membrane permeability.
On the other hand, the antibiotic in itself has no direct
inhibitory effect on membrane permeabilization, since the
presence of BFA at the time of addition of the aminoglyco-
side HB did not affect its entry into cells (Fig. 4A). The
presence of BFA from 5 or 7 h post-infection only had a
limited effect.
The effect of BFA on membrane permeabilization was
also tested using the construct coding for C + 6K. Treatment
of transfected BHK cells with BFA was also found to
diminish the permeabilization capacity of 6K (Fig. 4B). Our
findings point to the idea that once synthesized, 6K has to
travel or to send a signal through the vesicular system to
reach the plasma membrane.
The inhibitory action of BFA in mammalian cells is
reversible (Klausner et al., 1992; Miller et al., 1992). Thus,
to assess the reversibility of the BFA effect on membrane
leakiness, SV infected BHK cells were treated with BFA
from 2 to 6 h.p.i, when BFAwas removed. Three hours later,
the antibiotic HB readily entered the cytoplasm and
inhibited translation as in the untreated cultures (Fig. 5).
Finally, we also analyzed the activity of other compounds
on SV permeabilization. SV-infected cells were incubated
from 2 to 9 h.p.i with BFA, bafilomycin A1 (BFLA1),
nocodazole (NOC) or Ro-090179 (Ro). Thus, BFLA1, a
Fig. 4. Effect of BFA treatment on membrane permeabilization. (A) BFA
treatment of SV infected BHK cells. BHK cells were infected with 100 pfu/
cell and incubated with BFA (5 Ag/ml) added at different h.p.i as indicated
in the figure. Next, cells were radioactively labeled at 9 h.p.i in the absence
() or presence (+) 1 mM HB and BFA and processed for SDS-PAGE,
fluorography and autoradiography. (B) BFA treatment of electroporated
cells. BHK cells were electroporated with in vitro made RNA correspond-
ing to replicons rep C or rep C + 6K. BFA (5 Ag/ml) was added to the
culture medium at 2 h.p.e. At 16 h.p.e, cells were labeled in the absence ()
or presence (+) of 1 mM HB and BFA and processed for SDS-PAGE,
fluorography and autoradiography. The numbers below each line represent
the percentages obtained by dividing the densitometred values for cells
treated with HB by equivalent values for untreated cells. Protein C was used
to obtain the densitometred values.
Fig. 6. Effects of inhibitors on SV induced permeabilization. The effects of
5 Ag/ml BFA, 1 AM bafilomycin A1 (BFLA1), 40 AM nocodazol (NOC) or
10 Ag/ml Ro-090179 (Ro) were tested in wt SV infected cells at 100 pfu/
cell. Each compound was added to the cells at 2 h.p.i. At 9 h.p.i, cells were
labeled in the absence () or presence (+) of 1 mM HB and processed for
SDS-PAGE, fluorography and autoradiography. The numbers below each
line represent the percentages obtained by dividing the densitometred
values for cells treated with HB by equivalent values for untreated cells.
Protein C was used to obtain the densitometred values.
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nocodazole, which binds tubulin and disaggregates the
microtubule cytoskeleton (De Brabander et al., 1976;
Thyberg and Moskalewski, 1999), had no effect on SV-
induced late permeabilization (Fig. 6). Notably, the flavone
compound Ro-090179, which interferes with the retrogradeFig. 5. Reversibility of BFA treatment. BHK cells were infected with 100 pfu/cell (
h.p.i, BFA was withdrawn and fresh medium was added. At 6, 7, 8, 9 and 10 h.p
processed for SDS-PAGE, fluorography and autoradiography. The numbers belo
values for cells treated with HB by equivalent values for untreated cells. Proteintransport but has not effect on anterograde transport of the
vesicular system (Sandoval and Carrasco, 1997), diminished
membrane permeabilization.Discussion
Viral proteins that modify cell permeability can be
broadly divided into two molecular groups: glycoproteins
and viroporins (Gonzalez and Carrasco, 2003). During
virion entry, structural glycoproteins that contain the so-
called fusion peptide promote the merging of viral and
cellular membranes. At this stage of infection, early
membrane permeabilization takes place once the virus has
entered (Carrasco, 1994, 1995; Carrasco et al., 1993). The
co-entry of macromolecules into cells such as alpha-sarcin is
most probably promoted by the glycoproteins present in the
virions. Our findings reveal that small molecules such as the
antibiotic hygromycin B, pass into the cell interior less
efficiently at early time points during SV infection
compared to late time points. The molecular basis of the
co-entry of macromolecules is related to the proton motive
gradient created in endosomes (Carrasco, 1994; Guinea andSV) or infected and treated with BFA (5 Ag/ml) from 2 to 6 h.p.i (SV*). At 6
.i, cells were labeled in the absence () or presence (+) of 1 mM HB and
w each line represent the percentages obtained dividing the densitometred
C was used to obtain the densitometred values.
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hand, late permeabilization is a consequence of viral gene
expression late in infection. The synthesized glycoproteins
usually form multimers that aggregate in the budding
membranes to form a scaffold that wraps nucleocapsids.
Viroporins also oligomerize at membranes leading to the
formation of ion channels (Agirre et al., 2002; Ewart et al.,
1996; Gonzalez and Carrasco, 2003; Melton et al., 2002;
Nieva et al., 2003; Pinto et al., 1992; Premkumar et al.,
2004). Our present data indicate that the entry of HB late in
SV infection may occur through the pores formed by the
viral glycoproteins and viroporin 6K. These pores do not
permit the passage of macromolecules such as alpha-sarcin.
Thus, the molecular bases for the generation of early and
late membrane permeabilization are different.
Protein 6K from alphavirus has the capacity to alter
membranes both in bacteria and in mammalian cells (Sanz et
al., 1994, 2003a). Moreover, direct evidence has been found
for pore formation by RRV and BFV 6Ks (Melton et al.,
2002). Based on genetic studies, the main function of
viroporins including 6K involves correct virus particle
morphogenesis and release from infected cells (Corse and
Machamer, 2000; Gaedigk-Nitschko et al., 1990; Hughey
et al., 1992; Klimkait et al., 1990; Liljestrom et al., 1991;
Loewy et al., 1995; Sanz and Carrasco, 2001; Sanz et al.,
2003a).The experiments reported here reveal that 6K plays a
critical role in membrane permeabilization. Thus, the
expression of SV non-structural genes and C has no effect
on this phenomenon. Partial enhancement of permeabiliza-
tion was observed when E3E2 (PE2) glycoproteins were
synthesized, while much less activity was observed with E1
alone. Transport of E1 to the plasma membrane requires the
co-expression of PE2 (Barth and Garoff, 1997; Barth et al.,
1995; Sanz et al., 2003b). If PE2 is individually expressed,
transport to the plasma membrane is not impaired, but it
may be unable to multimerize. Perhaps, the arrest of E1 in
internal cellular compartments and the lack of proper
multimerization for E2 could explain their lower permeabi-
lizing capacity towards BHK cells. Interestingly, co-expres-
sion of both glycoproteins was more efficient at inducing the
entry of the antibiotic HB. The synthesis of PE2 and E1 in
the absence of 6K was achieved by infection with a mutant
that lacks the entire 6K gene. This SV variant shows defects
in virus budding, as described for an SFV 6K-deleted
mutant (Liljestrom et al., 1991; Loewy et al., 1995). Hence,
it could be that oligomeric glycoproteins accumulate at the
plasma membrane, leading to enhanced permeabilization.
Some viroporins including 6K from alphaviruses have
not been immunodetected at the plasma membrane but have
been observed in intracellular compartments (Gaedigk-
Nitschko and Schlesinger, 1990). These findings have
served as an argument for an indirect mechanism of action
of viroporins (De Jong et al., 2003, 2004). A few years ago,
we found that BFA was an effective inhibitor of the
membrane permeabilization promoted by poliovirus 2B
(On˜a, 2000), this also occurred when avian reovirus p10protein was analyzed (Bodelon et al., 2002). Brefeldin A
efficiently inhibits protein transport to the plasma membrane
(Klausner et al., 1992; Lippincott-Schwartz et al., 1989;
Miller et al., 1992; Yewdell and Bennink, 1989). Having
tested the effects of several agents on the membrane
permeabilization that develops during SV infection, or upon
expression of 6K, our results indicate that the flavone
compound Ro-090179 and, to a greater extent, BFA are able
to abrogate this altered membrane permeabilization. Despite
the presence of SV proteins to control levels, no entry of HB
is observed when BHK cells are treated with BFA. On the
other hand, on its own BFA does not induce permeabiliza-
tion and its effect is reversible after removal. These findings
indicate that an intact vesicular system is necessary for
membrane permeabilization by SV proteins.Materials and methods
Cell culture and viruses
Baby hamster kidney (BHK-21) cells were grown at
37 8C in Dulbecco’s Modified Eagle’s medium (DMEM)
supplemented with 5% fetal calf serum (FCS) and non-
essential amino acids. Wild-type (wt) and 6K-deleted SV
were propagated and titered in BHK-21 cultures.
Plasmids
pT7SVwt (Sanz and Carrasco, 2001) and pT7SVE3+E2
(Sanz et al., 2003b) have been described previously.
pT7SVD6K has a full deletion of the 6K sequence. It was
generated by inserting a PCR product digested with BssHII/
SplI into the same sites in pT7SVwt. The template used for
both primary PCRs was pT7SVwt. In one of the primary
reactions, we used a primer forward that had incorporated
the restriction site BssHII (TGT AAA GCG CGC CGT
GAG TGC) and a reverse primer containing the last 10
nucleotides of the E2 sequence plus the first 10 nts of E1
sequence (CAT GTT CGT AAG CAT TGG CC). The other
primary PCR used the inverted and complementary
sequence of the reverse primer described above as the
primer forward and a negative sense primer that contained
the SplI restriction site (ATT CGA CGT ACG CCT CAC
TCA TCT). Both PCR products were used as templates in
the secondary PCR with the outside oligonucleotides.
pT7SVC+D(E3/E2)E1 contains a deletion in the
sequence coding for the E3 and E2 proteins. The remaining
sequence codes for the 45 N-terminal amino acids of E3
fused to the 31 C-terminal amino acids of E2 followed by
E1. The digested BssHII/SplI product from pT7SVD6K
was inserted in the BssHII/SplI sites of pT7SV6K+E1
(Sanz et al., 2003b).
Constructions corresponding to SV replicons rep
C+D(E3/E2)6K and rep C have been previously described
(Sanz et al., 2003a).
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by inserting a PCR product that includes the 6K sequence
after the C sequence in the plasmid for rep C. As a result of
the cloning strategy, four codons encoding amino acids
SAHM were introduced between C and 6K.
Transfection of BHK cells
BHK cells were electroporated with in vitro synthesized
RNAs from the different plasmids. Subconfluent cells were
harvested, washed in ice-cold phosphate-buffered saline
(PBS), and resuspended in PBS at a density of about 2.5 
106 cell/ml. Fifty-microliter aliquots of T7 RNA polymerase
(Promega) transcription mixture with about 100 Ag RNA
from each different cDNA construct were added to 0.4 ml of
cells, and the mixtures were transferred to 2 mm electro-
poration cuvettes (Bio-Rad). Electroporation was performed
at room temperature as two consecutive 1.5-kV, 25-AF
pulses using a Gene Pulser apparatus (Bio-Rad) as described
elsewhere (Liljestrom et al., 1991). Control BHK cells were
electropored with 50 Al of transcription buffer in PBS. The
cells were then diluted in growth medium and seeded onto
culture plates.
Light microscopy
BHK cells were grown on glass cover slips and infected
with wt SV or D6K SV at a multiplicity of infection of 10
pfu/cell. At 40 min post-infection, the virus medium was
replaced with DMEM with 10% FCS. At 15 or 22 h post-
infection (h.p.i), cells were washed with PBS and fixed with
4% (w/v) paraformaldehyde in PBS for 10 min at room
temperature. Finally, cells were washed and mounted in
moviol by inverting the coverslip and examined using an
Axiovert 200 inverted microscope (Zeiss) with a 20  0.6
Plan-Apochromat Ph2 objective lens.
Permeabilization assays in infected or electroporated BHK
cells
Entry of the translation inhibitors hygromycin B (HB),
or the RNAase alpha-sarcin (a gift from Dr. Schuurman,
Michigan, USA) into the cells were used to detect
permeabilization by radioactive labeling of proteins.
Monolayers of BHK cells were infected with wt SV at a
multiplicity of 100 pfu/cell or transfected with in vitro
synthesized RNA from the different constructs. At several
h.p.i or hours post-electroporation (h.p.e), the cultures were
treated with 1 mM HB or 100 Ag/ml alpha-sarcin for 15
min, or left untreated. Next, proteins were labeled for 30
min with 200 Al methionine/cysteine-free DMEM supple-
mented with 1 Al Trans label [35S]Met-Cys (15 mCi/ml,
Amersham Biosciences) per well in the presence or
absence of the inhibitor. Cells were collected in buffer
sample, boiled for 4 min and analyzed by SDS-PAGE and
fluorography.Inhibiting permeabilization by BFA treatment
BHK cells were infected with 100 pfu/cell of wt SV.
Then at 2, 5, 7, or 9 h.p.i, the culture medium was replaced
with fresh medium containing 5 Ag/ml BFA as indicated in
each experiment. At 9 h.p.i, cells were labeled in the
presence or absence of 1 mM HB and BFA. Labeled
proteins were separated by SDS-PAGE, as indicated above.
The proteins in the gels were quantified by densitometry
using a GS-710 calibrated Imaging Densitometer (Bio-Rad).
A similar procedure was followed for the electroporated
BHK cells using RNA from the constructs pT7rep C + 6K
or pT7rep C. In this case, protein labeling was conducted at
16 h.p.e.
Effects of different compounds on SV induced
permeabilization
Brefeldin A (5 Ag/ml) (BFA, Sigma), Bafilomycin A1
(1 AM) (BFLA1) (purchased from Dr. Altendorf, Osna-
brqck University), NOC (40 AM) or Ro-090179 (10 Ag/ml)
(a gift from Drs. Ishitsuka and Yokose, Nippon Roche
Research Center, Kamakura, Japan) were added to the wt
SV infected cultures at 2 h.p.i. Then at 9 h.p.i, the cultures
were treated or not with 1 mM HB for 15 min followed by
labeling of the proteins in the presence of the compounds
with or without 1 mM HB. The samples were then
subjected to SDS-PAGE.Acknowledgments
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